We are live on ! Find out more
BCM

Bluefin Capital Management Portfolio holdings

AUM $399M
1-Year Est. Return 24.96%
This Fund
S&P 500
This Quarter Est. Return
+4.49%
1 Year Est. Return
+24.96%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.01B
AUM Growth
+$11.5M
Cap. Flow
+$73.1M
Cap. Flow %
7.26%
Top 10 Hldgs %
47.49%
Holding
702
New
252
Increased
126
Reduced
88
Closed
204
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBR icon
151
CALL
Petrobras
PBR
$134B
$832K 0.08%
746,200
+292,600
+65% +$1.94M
QCOM icon
152
Qualcomm
QCOM
$190B
$830K 0.08%
+15,494
New +$816K
LNW
153
DELISTED
Light & Wonder
LNW
$828K 0.08%
90,084
+59,594
+195% +$563K
TSLA icon
154
CALL
Tesla
TSLA
$1.44T
$827K 0.08%
262,500
-637,500
-71% -$9.66M
HYEM icon
155
VanEck Emerging Markets High Yield Bond ETF
HYEM
$520M
$825K 0.08%
+34,710
New +$808K
EUFN icon
156
iShares MSCI Europe Financials ETF
EUFN
$4.14B
$824K 0.08%
+52,580
New +$943K
VALE icon
157
PUT
Vale
VALE
$60.5B
$813K 0.08%
1,254,400
+239,000
+24% +$1.12M
PHYS icon
158
Sprott Physical Gold
PHYS
$15.7B
$799K 0.08%
72,747
-221,553
-75% -$2.32M
EMAG
159
DELISTED
VanEck Vectors Emerging Markets Aggregate Bond ETF
EMAG
$796K 0.08%
+37,448
New +$788K
XLV icon
160
State Street Health Care Select Sector SPDR ETF
XLV
$43.7B
$766K 0.08%
10,675
-325
-3% -$22.9K
MET icon
161
MetLife
MET
$61.7B
$756K 0.08%
21,309
+13,476
+172% +$526K
ABBV icon
162
AbbVie
ABBV
$466B
$739K 0.07%
11,937
-698
-6% -$42.5K
GVI icon
163
iShares Intermediate Government/Credit Bond ETF
GVI
$3.75B
$734K 0.07%
+6,476
New +$726K
MRK icon
164
Merck
MRK
$362B
$734K 0.07%
13,355
+9,328
+232% +$496K
PG icon
165
Procter & Gamble
PG
$340B
$729K 0.07%
8,607
+3,502
+69% +$287K
SWK icon
166
Stanley Black & Decker
SWK
$13.5B
$726K 0.07%
+6,528
New +$726K
NXPI icon
167
NXP Semiconductors
NXPI
$57.5B
$722K 0.07%
+9,222
New +$791K
DEO icon
168
Diageo
DEO
$47.6B
$716K 0.07%
+6,347
New +$686K
GEL icon
169
CALL
Genesis Energy
GEL
$1.79B
$710K 0.07%
626,000
+228,500
+57% +$8M
PM icon
170
Philip Morris
PM
$294B
$710K 0.07%
6,981
-4,019
-37% -$401K
SVXY icon
171
CALL
ProShares Short VIX Short-Term Futures ETF
SVXY
$261M
$708K 0.07%
200,500
+190,500
+1,905% +$10.3M
LNKD
172
CALL
DELISTED
LinkedIn Corporation
LNKD
$698K 0.07%
+30,000
New +$4.16M
UL icon
173
Unilever
UL
$133B
$696K 0.07%
+12,917
New +$663K
PBR icon
174
PUT
Petrobras
PBR
$134B
$694K 0.07%
1,290,800
+729,700
+130% +$4.83M
CALM icon
175
Cal-Maine
CALM
$3.4B
$681K 0.07%
+15,376
New +$725K

Similar funds

Bluefin Capital Management's Q2 2016 Portfolio in Review

As of Q2 2016, Bluefin Capital Management held 702 positions worth $1.01B, up 1.2% from $995M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Bluefin Capital Management deployed $73.1M of net new capital in Q2 2016, opening 252 new positions and adding to 126 existing holdings. Its largest new stake was Allergan plc: 443,994 shares worth $103M.

By sector, the portfolio is most concentrated in Miscellaneous at 54% of assets, down from 62% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $38M trimmed.

  • Bluefin Capital Management's largest Q2 2016 buy was Allergan plc: 443,994 shares worth $103M.
  • Bluefin Capital Management added most to EMC CORPORATION in Q2 2016, an estimated $17.8M increase.
  • Bluefin Capital Management's biggest Q2 2016 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $38M.
  • Bluefin Capital Management fully exited Baxter International in Q2 2016, selling an estimated $71.9M.
  • Bluefin Capital Management's ten largest holdings make up 47% of its $1.01B portfolio in Q2 2016.
  • Bluefin Capital Management opened 252 new positions and closed 204 in Q2 2016.
  • Bluefin Capital Management's portfolio value rose 1.2% quarter-over-quarter to $1.01B.

Based on Bluefin Capital Management's 13F filing for Q2 2016, filed 16 Aug 2016.